We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

99 hedge funds and large institutions have $12.4M invested in Zomedica Corp. in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 9

8% more funds holding

Funds holding: 92 → 99 (+7)

30% less capital invested

Capital invested by funds: $17.8M → $12.4M (-$5.37M)

38% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 21

Holders
99
Holders Change
+7
Holders Change %
+7.61%
% of All Funds
1.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
13
Reduced
21
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AI
Atom Investors
Texas
+$168K
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$38.6K
3
GCP
GSA Capital Partners
United Kingdom
+$34.3K
4
Cetera Investment Advisers
Cetera Investment Advisers
Illinois
+$33.6K
5
UBS Group
UBS Group
Switzerland
+$30.9K

Top Sellers

Rank Fund Capital Flow
1
ProShare Advisors
ProShare Advisors
Maryland
-$515K
2
CCM
Connective Capital Management
California
-$240K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$80.7K
4
BlackRock
BlackRock
New York
-$73.8K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$71.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
76
Bank of America
North Carolina
$1.04K +$548 +3,915 +119%
ADL
77
Asset Dedication LLC
California
$1K – – –
HFS
78
Hantz Financial Services
Michigan
$1K – – –
TFS
79
Thoroughbred Financial Services
Tennessee
$1K – – –
Fidelity Investments
80
Fidelity Investments
Massachusetts
$902 -$44.2K -315,655 -98%
SWM
81
Spire Wealth Management
Virginia
$730 -$44 -314 -6%
CFFP
82
Center for Financial Planning
Michigan
$730 – – –
TWC
83
TD Waterhouse Canada
Ontario, Canada
$562 – – –
TCM
84
TruNorth Capital Management
Michigan
$511 +$490 +3,500 New
TRCT
85
Tower Research Capital (TRC)
New York
$506 -$2.65K -18,967 -85%
GPFA
86
Game Plan Financial Advisors
Ohio
$438 -$70 -500 -14%
KFS
87
Kelly Financial Services
Massachusetts
$219 – – –
SWA
88
SOA Wealth Advisors
New York
$158 – – –
SIC
89
Salem Investment Counselors
North Carolina
$146 – – –
OPTFSNA
90
Old Point Trust & Financial Services N A
Virginia
$146 +$140 +1,000 New
JP Morgan Chase
91
JP Morgan Chase
New York
$133 – – –
KIG
92
Kessler Investment Group
Indiana
$50 – – –
HCP
93
Hexagon Capital Partners
Arkansas
$41 – – –
HPC
94
HM Payson & Co
Maine
$37 – – –
BWL
95
Bogart Wealth LLC
Virginia
$26 +$25 +180 New
HI
96
Harbour Investments
Wisconsin
$20 – – –
TCM
97
Tradewinds Capital Management
Washington
$15 – – –
Toronto Dominion Bank
98
Toronto Dominion Bank
Ontario, Canada
$3 – – –
ProShare Advisors
99
ProShare Advisors
Maryland
– -$515K -2,573,819 Closed
CCM
100
Connective Capital Management
California
– -$240K -1,200,000 Closed
1 2 3
4
5

ZOM Hedge Fund Activity: Q1 2024 in Review

99 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q1 2024, worth a combined $12.4M — down 30% from $17.8M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ZOM positions and 9 closed out — a net gain of 7 holders — while 13 added to existing stakes and 21 trimmed.

The largest buyer was Atom Investors, opening a new position worth an estimated $168K. The largest seller was ProShare Advisors, exiting entirely with an estimated $515K sold.

  • 99 institutional investors held Zomedica Corp. (ZOM) as of Q1 2024, up from 92 in Q4 2023.
  • Funds reported $12.4M of Zomedica Corp. stock for Q1 2024, down 30% quarter-over-quarter.
  • 16 funds opened new Zomedica Corp. positions in Q1 2024 and 9 closed out, a net change of +7 holders.
  • The largest Zomedica Corp. buyer in Q1 2024 was Atom Investors, an estimated $168K added.
  • The largest Zomedica Corp. seller in Q1 2024 was ProShare Advisors, an estimated $515K sold.

Based on aggregated 13F filings for Q1 2024.